GlassScriptPhysician profile
Michael W Grisanti
NPI 1851326177
$31,945.70
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $5,041 · 2021: $15.48 · 2022: $77.15 · 2023: $33.35 · 2024: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $24,045.79 | 2019 | |
| Mallinckrodt Hospital Products INC. | $4,777.35 | 2020-2024 | Acthar |
| Abbvie INC. | $434.83 | 2019-2020 | |
| Janssen Biotech, INC. | $388.04 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $355.06 | 2019-2022 | |
| Genentech USA, INC. | $278.94 | 2019-2020 | |
| Pfizer INC. | $253.29 | 2019-2020 | |
| Horizon Therapeutics Plc | $253.14 | 2019-2020 | |
| Genzyme Corporation | $193.78 | 2019-2023 | |
| Amgen INC. | $154.97 | 2019-2020 | |
| Celgene Corporation | $140.82 | 2019 | |
| Glaxosmithkline, LLC. | $129.62 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $114.22 | 2019 | |
| Ucb, INC. | $94.65 | 2019 | |
| Radius Health, INC. | $76.25 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $36.99 | 2019 | |
| Lilly USA, LLC | $33.70 | 2019 | |
| Sobi, INC | $33.67 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.37 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $27.56 | 2019-2020 | |
| Sanofi Pasteur INC. | $24.06 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.03 | 2019 | |
| Gilead Sciences, INC. | $18.19 | 2019 | |
| Grifols USA, LLC | $14.51 | 2019 | |
| Endo Pharmaceuticals INC. | $11.87 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grisanti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.